Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA issues two observations after inspection of Lupin’s Pithampur unit
The inspection was carried out between February 3 and February 11, 2020
Lupin said the US health regulator has issued two…
Dr Reddy’s to acquire Wockhardt’s select generics for Rs 1850 crore
The business consists of a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, VMS, dermatology, pain…
Merck launches BrightLab
The cloud-based inventory management and instrument connectivity platform will allow scientists and lab managers to track and…
Eminence Business Media concludes 3rd Annual Pharma Project and Portfolio Management Summit 2020
The theme of the summit was 'Grooming Project and Portfolio Management teams for opportunities and uncertainties'
Eminence…
2019-nCoV must reform India Pharma Inc
Urgent regulatory reform is needed to spur more proactive policies for proposed bulk drug and API parks which will make the…
Centre notifies medical equipment used on humans or animals as ‘drugs’
Upon the expiry of these time periods, all provisions of the Medical Devices Rules 2017 will apply to the respective devices
To…
Prolongation of coronavirus outbreak in China could hit Indian pharma sector
China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates in 2018-19 at USD 2,405.42 million
Marksans Pharma gets EIR from US FDA for New York unit
In a regulatory filing, the company announced "receipt of the EIR from US Food and Drug Administration (US FDA) in respect of…
JB Chemicals Gujarat unit passes US FDA inspection with one observation
The observation does not impact continuity of the business and the company would continue its manufacturing activities in current…
Cadila Healthcare gets EIR from US FDA for its Ahmedabad facility
The facility completed the US FDA audit from December 16 to 20, 2019 with zero 483 observations, it added